Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Clinical Relevance of Genes Commonly Deleted in Childhood B-Cell Precursor ALL (BCP-ALL)

Claire Schwab, BSc, Lucy Chilton, Amir Enshaie, PhD, Heather Morrison, BSc, Lisa Jones, BSc, Halima A Al-Shehhi, MD, Amy Erhorn, PhD, Lisa J Russell, Ajay J Vora, FRCPath, Christopher D Mitchell, FRCPCH, Sue M Richards, PhD, Nicholas Goulden, FRCPath, Sally Kinsey, FRCPath, Anthony V. Moorman, PhD, Christine J Harrison, PhD, FRCPath

Blood (2012) 120 (21): 290.

https://doi.org/10.1182/blood.V120.21.290.290

Published: 2012

Journal Articles

Treatment Intensification Improves Outcome in Children with iAMP21 positive ALL

Anthony V. Moorman, PhD, Hazel M Robinson, PhD, Sue M Richards, PhD, Claire Schwab, BSc, Christopher D Mitchell, FRCPCH, Nicholas Goulden, FRCPath, Ajay J Vora, FRCPath, Christine J Harrison, PhD, FRCPath

Blood (2012) 120 (21): 656.

https://doi.org/10.1182/blood.V120.21.656.656

Published: 2012

Journal Articles

Demographic, clinical, and outcome features of children with acute lymphoblastic leukemia and CRLF2 deregulation: results from the MRC ALL97 clinical trial

Hannah M. Ensor, Claire Schwab, Lisa J. Russell, Sue M. Richards, Heather Morrison, Dino Masic, Lisa Jones, Sally E. Kinsey, Ajay J. Vora, Christopher D. Mitchell, Christine J. Harrison, Anthony V. Moorman

Blood (2011) 117 (7): 2129–2136.

https://doi.org/10.1182/blood-2010-07-297135

Published: 2011

Includes: Supplemental data

Journal Articles

Prognostic Relevance of Cytogenetics in Childhood Acute Lymphoblastic Leukaemia (ALL): Final Results From MRC ALL97.

Anthony V Moorman, Hannah M Ensor, Lucy Chilton, Sue M Richards, Sally E Kinsey, Ajay J Vora, Christopher D Mitchell, Christine J Harrison

Blood (2009) 114 (22): 88.

https://doi.org/10.1182/blood.V114.22.88.88

Published: 2009

Journal Articles

The Spectrum and Prognostic Relevance of Additional Abnormalities, Involving 12p and 21q, in Children with ETV6 - RUNX1 Positive Acute Lymphoblastic Leukaemia (ALL)

Anthony V Moorman, Zoe J Konn, Kerry E Barber, Sarah L Wright, Adam RM Stewart, Helen Parker, Sue M Richards, Sally E Kinsey, Osborn B Eden, Ajay J Vora, Christopher D Mitchell, Jonathan C Strefford, Christine J Harrison

Blood (2008) 112 (11): 430.

https://doi.org/10.1182/blood.V112.11.430.430

Published: 2008

Journal Articles

The Combination of Fludarabine and Cyclophosphamide Has a Beneficial Effect on the Incidence of Hemolytic Anemia in Chronic Lymphocytic Leukemia. Results from the UK LRF CLL4 Trial.

Claire E. Dearden, MD, Rachel L. Wade, MSc, Monica Else, MSc, Sue M. Richards, DPhil, Don W. Milligan, MD, Terry J. Hamblin, MD, Daniel Catovsky, DSc

Blood (2007) 110 (11): 2044.

https://doi.org/10.1182/blood.V110.11.2044.2044

Published: 2007

Journal Articles

Baseline Characteristics Associated with Quality of Life in CLL Patients Requiring Therapy.

Monica Else, MSc, Alastair G. Smith, MD, Sue M. Richards, DPhil, Kim Cocks, MSc, Shirley Crofts, MSc, Daniel Catovsky, MD

Blood (2007) 110 (11): 2062.

https://doi.org/10.1182/blood.V110.11.2062.2062

Published: 2007

Journal Articles

Cytogenetic-Specific Heterogeneity in the Kinetics of Minimal Residual Disease (MRD) Clearance in Childhood Acute Lymphoblastic Leukaemia (ALL).

Anthony V. Moorman, Sue M. Richards, Jerry P. Hancock, Chris D. Mitchell, Ajay J. Vora, Christine J. Harrison, Nick J. Goulden

Blood (2007) 110 (11): 1426.

https://doi.org/10.1182/blood.V110.11.1426.1426

Published: 2007

Journal Articles

Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial

Anthony V. Moorman, Christine J. Harrison, Georgina A. N. Buck, Sue M. Richards, Lorna M. Secker-Walker, Mary Martineau, Gail H. Vance, Athena M. Cherry, Rodney R. Higgins, Adele K. Fielding, Letizia Foroni, Elisabeth Paietta, Martin S. Tallman, Mark R. Litzow, Peter H. Wiernik, Jacob M. Rowe, Anthony H. Goldstone, Gordon W. Dewald, on behalf of the Medical Research Council (MRC)/National Cancer Research Institute (NCRI) Adult Leukaemia Working Party of the United Kingdom and the Eastern Cooperative Oncology Group

Blood (2006) 109 (8): 3189–3197.

https://doi.org/10.1182/blood-2006-10-051912

Published: 2006

Includes: Supplemental data

Journal Articles

Drug Sensitivity by TRAC (DiSC) Assay as a Prognostic Factor for Patient Response in Untreated CLL: Results from the UK LRF CLL4 Trial.

Andrew G. Bosanquet, PhD, Steve L. Raper, BSc, Justin Durant, Sheila M. Scadding, David Graham Oscier, MD, Sue M. Richards, PhD, Daniel Catovsky, MD PhD, on Behalf of the NCRI CLL Working Group

Blood (2006) 108 (11): 303.

https://doi.org/10.1182/blood.V108.11.303.303

Published: 2006

Journal Articles

Karyotype Is an Independent Prognostic Factor in Adult Acute Lymphoblastic Leukaemia (ALL): Analysis of Cytogenetic Data from 1,235 Patients on the Medical Research Council (MRC) UKALLXII /Eastern Cooperative Oncology Group (ECOG) 2993 Trial.

Anthony V. Moorman, Christine J. Harrison, Sue M. Richards, Adele Fielding, Martin S. Tallman, Mark R. Litzow, Jacob M. Rowe, Anthony H. Goldstone, Gordon W. Dewald

Blood (2005) 106 (11): 331.

https://doi.org/10.1182/blood.V106.11.331.331

Published: 2005

Journal Articles

The Outcome of 551 1 st CR Transplants in Adult ALL from the UKALL XII/ECOG 2993 Study.

Anthony H. Goldstone, Hillard J. Lazarus, Sue M. Richards, Mark R. Litzow, Raj Chopra, Alan Burnett, Peter H. Wiernik, Ian M. Franklin, H. G. Prentice, Martin Tallman, G. Harrison, Jill Durrant, Jacob Rowe

Blood (2004) 104 (11): 615.

https://doi.org/10.1182/blood.V104.11.615.615

Published: 2004

Journal Articles

Adult Patients with Acute Lymphoblastic Leukemia (ALL) and Central Nervous System (CNS) Leukemia at Diagnosis May Attain Durable Complete Remissions (CR). Results from the International ALL Trial (MRC UKALL-XII/ECOG E2993).

Hillard M. Lazarus, MD, Sue M. Richards, Raj Chopra, MD, Mark R. Litzow, MD, Alan K. Burnett, MD, Peter H. Wiernik, MD, Ian M. Franklin, MD, Martin S. Tallman, MD, G. Buck, Jill Durrant, Jacob M. Rowe, MD, Anthony H. Goldstone, MD

Blood (2004) 104 (11): 4484.

https://doi.org/10.1182/blood.V104.11.4484.4484

Published: 2004

Journal Articles

Outcome heterogeneity in childhood high-hyperdiploid acute lymphoblastic leukemia

Anthony V. Moorman, Sue M. Richards, Mary Martineau, Kan Luk Cheung, Hazel M. Robinson, G. Reza Jalali, Zoë J. Broadfield, Rachel L. Harris, Kerry E. Taylor, Brenda E. S. Gibson, Ian M. Hann, Frank G. H. Hill, Sally E. Kinsey, Tim O. B. Eden, Christopher D. Mitchell, Christine J. Harrison, for the United Kingdom Medical Research Council's Childhood Leukaemia Working Party

Blood (2003) 102 (8): 2756–2762.

https://doi.org/10.1182/blood-2003-04-1128

Published: 2003

NARROW

Clinical Relevance of Genes Commonly Deleted in Childhood B-Cell Precursor ALL (BCP-ALL)

Treatment Intensification Improves Outcome in Children with iAMP21 positive ALL

Demographic, clinical, and outcome features of children with acute lymphoblastic leukemia and CRLF2 deregulation: results from the MRC ALL97 clinical trial

Prognostic Relevance of Cytogenetics in Childhood Acute Lymphoblastic Leukaemia (ALL): Final Results From MRC ALL97.

The Spectrum and Prognostic Relevance of Additional Abnormalities, Involving 12p and 21q, in Children with ETV6 - RUNX1 Positive Acute Lymphoblastic Leukaemia (ALL)

The Combination of Fludarabine and Cyclophosphamide Has a Beneficial Effect on the Incidence of Hemolytic Anemia in Chronic Lymphocytic Leukemia. Results from the UK LRF CLL4 Trial.

Baseline Characteristics Associated with Quality of Life in CLL Patients Requiring Therapy.

Cytogenetic-Specific Heterogeneity in the Kinetics of Minimal Residual Disease (MRD) Clearance in Childhood Acute Lymphoblastic Leukaemia (ALL).

Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial

Drug Sensitivity by TRAC (DiSC) Assay as a Prognostic Factor for Patient Response in Untreated CLL: Results from the UK LRF CLL4 Trial.

Karyotype Is an Independent Prognostic Factor in Adult Acute Lymphoblastic Leukaemia (ALL): Analysis of Cytogenetic Data from 1,235 Patients on the Medical Research Council (MRC) UKALLXII /Eastern Cooperative Oncology Group (ECOG) 2993 Trial.

The Outcome of 551 1 st CR Transplants in Adult ALL from the UKALL XII/ECOG 2993 Study.

Adult Patients with Acute Lymphoblastic Leukemia (ALL) and Central Nervous System (CNS) Leukemia at Diagnosis May Attain Durable Complete Remissions (CR). Results from the International ALL Trial (MRC UKALL-XII/ECOG E2993).

Outcome heterogeneity in childhood high-hyperdiploid acute lymphoblastic leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only